Weave Bio is an AI-native, life sciences platform company that provides a technically robust, AI-enabled platform for major pain points inherent in the pharma and biotech industries. Our flagship product, AutoIND, is the first offering on Weave’s comprehensive Regulatory Automation and Lifecycle Management (ReALM) platform. With AutoIND we streamline the Investigational New Drug (IND) application process and enable drug development teams to build a living record of their therapeutic candidates, delivering significant improvements in both efficiency and quality. AutoIND automatically generates content based on users’ own source data, regulatory guidelines, and public information. The solution offers a robust, in-platform process for quality review and significantly enhances editing capabilities and oversight for teams. While conventional IND preparation processes can take more than a year, AutoIND can produce a first draft of an IND in a single day and reduce the overall time to gen